HDMX Folds the Nascent p53 mRNA following Activation by the ATM Kinase

Molecular Cell

Volumn 54, Issue 3, 2014, Pages 500-511

  Malbert Colas, Laurence ^a   Ponnuswamy, Anand ^a,b   Olivares Illana, Vanesa ^c   Tournillon, Anne Sophie ^a   Naski, Nadia ^a   Fåhraeus, Robin ^a  

^a INSERM   (France)

^b MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^c UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN HDMX; PROTEIN P53; SERINE; SERINE 403; TRANS ACTING FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CONFORMATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PROTEIN SYNTHESIS; RIBOSOME;

ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BASE SEQUENCE; DNA DAMAGE; GENE EXPRESSION REGULATION; HUMANS; INVERTED REPEAT SEQUENCES; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA FOLDING; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; SF9 CELLS; SPODOPTERA; SUBSTRATE SPECIFICITY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84899867316     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2014.02.035     Document Type: Article

References (40)

1. Ahuja H.G., Testa M.P., Cline M.J. Variation in the protein coding region of the human p53 gene. Oncogene 1990, 5:1409-1410.
2. Biderman L., Manley J.L., Prives C. Mdm2 and MdmX as Regulators of Gene Expression. Genes Cancer 2012, 3:264-273.
3. Bourougaa K., Naski N., Boularan C., Mlynarczyk C., Candeias M.M., Marullo S., Fåhraeus R. Endoplasmic reticulum stress induces G2 cell-cycle arrest via mRNA translation of the p53 isoform p53/47. Mol. Cell 2010, 38:78-88.
4. Breaker R.R. Prospects for riboswitch discovery and analysis. Mol. Cell 2011, 43:867-879.
5. Bushell M., Stoneley M., Kong Y.W., Hamilton T.L., Spriggs K.A., Dobbyn H.C., Qin X., Sarnow P., Willis A.E. Polypyrimidine tract binding protein regulates IRES-mediated gene expression during apoptosis. Mol. Cell 2006, 23:401-412.
6. Candeias M.M., Powell D.J., Roubalova E., Apcher S., Bourougaa K., Vojtesek B., Bruzzoni-Giovanelli H., Fåhraeus R. Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation. Oncogene 2006, 25:6936-6947.
7. Candeias M.M., Malbert-Colas L., Powell D.J., Daskalogianni C., Maslon M.M., Naski N., Bourougaa K., Calvo F., Fåhraeus R. P53 mRNA controls p53 activity by managing Mdm2 functions. Nat. Cell Biol. 2008, 10:1098-1105.
8. Chen L., Gilkes D.M., Pan Y., Lane W.S., Chen J. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. EMBO J. 2005, 24:3411-3422.
9. Cristofari G., Darlix J.L. The ubiquitous nature of RNA chaperone proteins. Prog. Nucleic Acid Res. Mol. Biol. 2002, 72:223-268.
10. Dethoff E.A., Chugh J., Mustoe A.M., Al-Hashimi H.M. Functional complexity and regulation through RNA dynamics. Nature 2012, 482:322-330.
11. Dever T.E., Feng L., Wek R.C., Cigan A.M., Donahue T.F., Hinnebusch A.G. Phosphorylation of initiation factor 2 alpha by protein kinase GCN2 mediates gene-specific translational control of GCN4 in yeast. Cell 1992, 68:585-596.
12. Djuranovic S., Nahvi A., Green R. A parsimonious model for gene regulation by miRNAs. Science 2011, 331:550-553.
13. Draper D.E. A guide to ions and RNA structure. RNA 2004, 10:335-343.
14. Fåhraeus R., Olivares-Illana V. MDM2's social network. Oncogene 2013.
15. Fernández-Miragall O., Martínez-Salas E. Invivo footprint of a picornavirus internal ribosome entry site reveals differences in accessibility to specific RNA structural elements. J.Gen. Virol. 2007, 88:3053-3062.
16. Frieda K.L., Block S.M. Direct observation of cotranscriptional folding in an adenine riboswitch. Science 2012, 338:397-400.
17. Fu L., Minden M.D., Benchimol S. Translational regulation of human p53 gene expression. EMBO J. 1996, 15:4392-4401.
18. Gajjar M., Candeias M.M., Malbert-Colas L., Mazars A., Fujita J., Olivares-Illana V., Fåhraeus R. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage. Cancer Cell 2012, 21:25-35.
19. Gannon H.S., Woda B.A., Jones S.N. ATM phosphorylation of Mdm2 Ser394 regulates the amplitude and duration of the DNA damage response in mice. Cancer Cell 2012, 21:668-679.
20. Harding H.P., Zhang Y., Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999, 397:271-274.
21. Hayes V.M., Bleeker W., Verlind E., Timmer T., Karrenbeld A., Plukker J.T., Marx M.P., Hofstra R.M., Buys C.H. Comprehensive TP53-denaturing gradient gel electrophoresis mutation detection assay also applicable to archival paraffin-embedded tissue. Diagn. Mol. Pathol. 1999, 8:2-10.
22. Holcik M., Sonenberg N. Translational control in stress and apoptosis. Nat. Rev. Mol. Cell Biol. 2005, 6:318-327.
23. Jedamzik B., Eckmann C.R. Analysis of RNA-protein complexes by RNA coimmunoprecipitation and RT-PCR analysis from Caenorhabditis elegans. Cold Spring Harb Protoc 2009, 2009:t5300.
24. Komar A.A., Hatzoglou M. Internal ribosome entry sites in cellular mRNAs: mystery of their existence. J.Biol. Chem. 2005, 280:23425-23428.
25. Lev Bar-Or R., Maya R., Segel L.A., Alon U., Levine A.J., Oren M. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc. Natl. Acad. Sci. USA 2000, 97:11250-11255.
26. Lewis S.M., Holcik M. For IRES trans-acting factors, it is all about location. Oncogene 2008, 27:1033-1035.
27. Liebeg A., Waldsich C. Probing RNA structure within living cells. Methods Enzymol. 2009, 468:219-238.
28. Mandal M., Boese B., Barrick J.E., Winkler W.C., Breaker R.R. Riboswitches control fundamental biochemical pathways in Bacillus subtilis and other bacteria. Cell 2003, 113:577-586.
29. Maya R., Balass M., Kim S.T., Shkedy D., Leal J.F., Shifman O., Moas M., Buschmann T., Ronai Z., Shiloh Y., et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 2001, 15:1067-1077.
30. Oscier D.G., Gardiner A.C., Mould S.J., Glide S., Davis Z.A., Ibbotson R.E., Corcoran M.M., Chapman R.M., Thomas P.W., Copplestone J.A., et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002, 100:1177-1184.
31. Ray P.S., Grover R., Das S. Two internal ribosome entry sites mediate the translation of p53 isoforms. EMBO Rep. 2006, 7:404-410.
32. Spriggs K.A., Bushell M., Willis A.E. Translational regulation of gene expression during conditions of cell stress. Mol. Cell 2010, 40:228-237.
33. Strauss B.S. Silent and multiple mutations in p53 and the question of the hypermutability of tumors. Carcinogenesis 1997, 18:1445-1452.
34. Tinton S.A., Buc-Calderon P.M. Hypoxia increases the association of 4E-binding protein 1 with the initiation factor 4E in isolated rat hepatocytes. FEBS Lett. 1999, 446:55-59.
35. Vousden K.H., Lane D.P. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:275-283.
36. Wade M., Wang Y.V., Wahl G.M. The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol. 2010, 20:299-309.
37. Waldsich C., Grossberger R., Schroeder R. RNA chaperone StpA loosens interactions of the tertiary structure in the td group I intron invivo. Genes Dev. 2002, 16:2300-2312.
38. Wang Y.V., Leblanc M., Wade M., Jochemsen A.G., Wahl G.M. Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases. Cancer Cell 2009, 16:33-43.
39. Wells S.E., Hughes J.M., Igel A.H., Ares M. Use of dimethyl sulfate to probe RNA structure invivo. Methods Enzymol. 2000, 318:479-493.
40. Yin Y., Stephen C.W., Luciani M.G., Fåhraeus R. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products. Nat. Cell Biol. 2002, 4:462-467.